October 8, 2008
REYKJAVIK, Iceland, Oct 08, 2008 -- Enables women to understand whether they may benefit from more intensive screening, monitoring or preventive drug therapy deCODE genetics today announced the launch of deCODE BreastCancer(TM), a new tool for assessing risk of the common forms of breast cancer. For the first time, a woman concerned about breast cancer [...]
October 8, 2008
NEWCASTLE UPON TYNE, England, Oct 08, 2008 -- Nonlinear Dynamics Ltd, the world leading developer of analysis solutions for proteomics and biomarker discovery, has announced that Boston University's Cardiovascular Proteomics Center (CPC) Core Laboratory have chosen the Progenesis software range for their label free LC-MS and 2D data analyses. Progenesis LC-MS v1.1 offers users an [...]
Luminex Corporation Receives Clearance from Health Canada for xTAG(TM) Respiratory Viral Panel
October 8, 2008
Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, today announced that it has received clearance from Health Canada for its xTAG(TM) Respiratory Viral Panel (RVP). xTAG RVP is a unique, groundbreaking test that, from one patient sample, simultaneously detects the 18 respiratory viruses and subtypes that are responsible for the majority of respiratory [...]
October 8, 2008
Tripos International, a leading provider of drug discovery informatics products and services, today announced a collaboration agreement with AstraZeneca to develop a new drug discovery workflow solution. The centerpiece of the collaboration effort will be the development of Tripos' new Muse(TM) de novo design product, which is targeted for commercial release in the fourth quarter [...]
Helicos Ships Genetic Analysis System To Stanford University
October 7, 2008
CAMBRIDGE, Mass.--Helicos BioSciences Corporation (NASDAQ:HLCS - News) today announced the shipment of a Helicos™ Genetic Analysis System to Stanford University for use in research. The unique ability of the Helicos Genetic Analysis System to obtain sequence information from individual DNA molecules couples unparalleled throughput and scalability with an unbiased view of DNA and RNA that [...]
Pharsight and InforSense Establish Strategic Partnership.
October 7, 2008
Pharsight Expands Global Presence Through InforSense Chinese Distributor, Companies to Collaborate On Use of Biomarkers in PK/PD Modeling MOUNTAIN VIEW, Calif., and LONDON, Oct 7, 2008 -- Pharsight Corporation, a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, and InforSense Ltd., the leading provider of next-generation business and scientific [...]
Cytori Receives Two Patent Allowances Related to Uses of the Celution(R) System Output
October 7, 2008
Cytori Therapeutics (NASDAQ: CYTX) received two Notices of Allowance from the U.S. Patent & Trademark Office for patents, which cover methods related to the Celution(R) System output. These patent allowances add specific commercial applications to U.S. Patent No. 7,390,484, issued in June 2008, which covers the Celution System technology that processes adipose-derived stem and regenerative [...]
Invitrogen Files Merger Notification With European Commission
October 7, 2008
Invitrogen Corporation (NASDAQ:IVGN) today announced that it has filed the necessary formal notification to the European Commission with respect to its pending acquisition of Applied Biosystems Inc. (NYSE:ABI). Under European Commission rules, the Commission has 25 business days following the date of notification to respond to the filing. The company continues to expect the transaction [...]
October 7, 2008
Technology expected to aid drug discovery by allowing for the rapid synthesis of molecules using a single reaction ST. LOUIS, Oct. 7 -- Sigma-Aldrich (Nasdaq: SIAL - News) is pleased to announce that it has signed an exclusive licensing agreement with the University of Illinois at Urbana-Champaign allowing Sigma-Aldrich to offer research quantities of powerful [...]
South African Core Lab Adopts Affymetrix Technology for Genomic Studies
October 7, 2008
Affymetrix Inc., (Nasdaq:AFFX) today announced that one of South Africa's largest public core labs has begun offering genomic research on the Affymetrix GeneChip(R) platform. The Centre for Proteomic and Genomic Research (CPGR) is using many Affymetrix GeneChip arrays, such as the exon array and the SNP Array 6.0, to explore applications with molecular diagnostics potential, [...]
